This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by exploring a novel area of research exploring the link between vascular disease and Alzheimer's Disease.
This chapter provides an overview of neurodevelopmental disabilities, emphasizing their lifelong impact, diverse etiologies, and the importance of early genetic testing and individualized, context-aware interventions. It aligns with SDG 3 (Good Health and Well-being) by promoting comprehensive care and lifelong health planning, and SDG 10 (Reduced Inequalities) by advocating equitable access to diagnostic tools, targeted treatments, and inclusive approaches that optimize functional and societal participation goals
This study highlights that infertility in Southern Ghana often leads women to face stigma and cultural barriers when considering adoption, underscoring the need for community engagement to support their decision-making process.
The article investigates the role of CD38, an enzyme implicated in neuroinflammation and cellular senescence, in the context of vascular dementia (VaD). It demonstrates that inhibiting CD38 can mitigate cerebrovascular endothelial cell dysfunction, blood-brain barrier disruption, neuroinflammation, and white matter damage, ultimately alleviating cognitive impairment in a mouse model of VaD. The findings suggest that targeting CD38 may offer a promising therapeutic strategy for addressing the vascular and neurological deficits associated with VaD
